Cyril Amarchand Mangaldas advises Organon & Co., a global healthcare company, in its acquisition by Sun Pharmaceutical Holdings USA, Inc.
The transaction marks a significant cross-border healthcare deal involving a global pharmaceutical portfolio spanning women’s health, biosimilars, and specialty therapies.